Bocsci11

BOC Sciences specializes in small molecules synthesis, biosynthesis, purification and characterization. We have been supplying high quality products for our esteemed customers in academia, pharmaceuticals, biotech, CDMO, material sciences and agriculture industry to support their research and production needs. We work closely with our synthetic laboratories, fermentation labs, OEM and global partners and proudly offer a full range of product portfolio.

BOC Sciences specializes in small molecules synthesis, biosynthesis, purification and characterization. We have been supplying high quality products for our esteemed customers in academia, pharmaceuticals, biotech, CDMO, material sciences and agriculture industry to support their research and production needs. We work closely with our synthetic laboratories, fermentation labs, OEM and global partners and proudly offer a full range of product portfolio.

BOC Sciences offers a wide range of high quality research chemicals and biochemicals including amino acids, peptides and resins for laboratory and scientific use. We pay the most careful attention to the quality of our products. All products are manufactured with rigorous guidelines and are accompanied with certificates of analysis, HPLC, Mass Spectrum, and HMNR. BOC Sciences’ products have been cited by many top peer-reviewed journals such as Nature, Cell and Science.

BOC Sciences offers a wide range of high quality research chemicals and biochemicals including amino acids, peptides and resins for laboratory and scientific use. We pay the most careful attention to the quality of our products. All products are manufactured with rigorous guidelines and are accompanied with certificates of analysis, HPLC, Mass Spectrum, and HMNR. BOC Sciences’ products have been cited by many top peer-reviewed journals such as Nature, Cell and Science.

BOC Sciences is a life sciences group with its headquarters in the NY. BOC Sciences provides the most complete antibody-drug conjugate (ADC) development service solutions for the pharmaceutical industry. Working with companies and academic groups all over the world, including most of the top biopharmaceutical companies, BOC Sciences supports the development and manufacture of antibody drug conjugates.

BOC Sciences is a life sciences group with its headquarters in the NY. BOC Sciences provides the most complete antibody-drug conjugate (ADC) development service solutions for the pharmaceutical industry. Working with companies and academic groups all over the world, including most of the top biopharmaceutical companies, BOC Sciences supports the development and manufacture of antibody drug conjugates.

BOC Sciences' customized carbohydrate bio-binding service includes experimental design and the development of customer-required solutions and procedures for the preparation of conjugates. Over the past two decades, we have accumulated a portfolio of products that modify and combine carbohydrates into many other small or large molecules. With the comprehensive advanced platform, BOC Sciences provides global clients with peptide glycosylation services to promote your research.

As a leading service provider in the field of drug discovery and research, BOC Sciences is fully competent and dedicated to serving one-stop molecule labeling services which has be used in various detection and assay system. With the comprehensive advanced platform, BOC Sciences provides global clients with protein/peptide crosslinking service to promote your research.

BOC Sciences is a leading contract development and manufacturing company, we provide quality products and services to our global partners. We focus on fermentation-related projects, combining microbial strain development, fermentation process optimization and other technologies with GMP manufacturing in order to meet the needs of our customers in the pharmaceutical, food and agricultural industries.

BOC Sciences is a leading contract development and manufacturing company, we provide quality products and services to our global partners. We focus on fermentation-related projects, combining microbial strain development, fermentation process optimization and other technologies with GMP manufacturing in order to meet the needs of our customers in the pharmaceutical, food and agricultural industries.

BOC Sciences is a US-based provider of specially designed scaffolds and building blocks products and services for academic and governmental research institutes, pharmaceutical and biotechnology industry.

BOC Sciences is a US-based provider of specially designed scaffolds and building blocks products and services for academic and governmental research institutes, pharmaceutical and biotechnology industry.

BOC Sciences' quality control (QC) service can keep your medicines within a safe and effective range. Quality control is a complicated and meticulous work, and a small omission will affect the final product quality. Once quality control errors occur, a large number of substandard products will not only increase the cost of the project, but may also delay the time to market for the drug, causing immeasurable losses.

As a world-leading CDMO company, BOC Sciences has accumulated many years of experience in process optimization. Our extensive expertise has helped customers optimize processes for thousands of compounds, with more than 100 of them reaching the commercialization stage.

BOC Sciences is committed to the development and manufacture of chiral catalysts and ligands, chiral auxiliaries and chiral synthetic building blocks. We can provide high-quality, fast and economical resolution, synthesis, production, processing, analysis and testing services for universities, scientific research institutes, domestic and foreign pharmaceutical companies and new drug research and development institutions.

BOC Sciences is committed to the development and manufacture of chiral catalysts and ligands, chiral auxiliaries and chiral synthetic building blocks. We can provide high-quality, fast and economical resolution, synthesis, production, processing, analysis and testing services for universities, scientific research institutes, domestic and foreign pharmaceutical companies and new drug research and development institutions.

Assessing the developability of a therapeutic candidate helps to select the candidate with the most stable profile and to avoid potential problems in later development. In general, therapeutic developability assessment refers to the evaluation of the drug-like properties, manufacturability, and safety of a potential pharmaceutical candidate, and it often includes the assessment of the biophysical and chemical properties of the drug candidate.

Knowledge of properties of the drug substances and drug products plays an important role in determining the optimal formulation method for preclinical and Phase I studies. Analytical testing is a critical tool to make you have a complete understanding of product quality. BOC Sciences is committed to learning as much as possible about drug substance in the early stages. With our experience in multiple chemical classes, our experts have developed advanced analytical methods for different drug substances and drug products.

Glutamate receptors are proved to play an important role in many neurological disorders. They are localized on neuronal and non-neuronal cells and are capable of mediating rapid excitatory synaptic transmission in the central nervous system. These receptors can regulate a wide range of processes in the brain, spinal cord, retina and peripheral nervous system. There are two major classes of glutamate receptors: ionotropic receptors and metabotropic receptors. Ionic glutamate receptors are ligand-gated channels whose agonists include AMPA, Kainate, and NMDA.

Protein kinases are enzymes that regulate the energy balance by catalyzing phosphorylation. Thus, kinases are critical in cell signaling, metabolism, protein regulation, cellular transport and many other cellular pathways. Over the past 15 years, protein kinases have become the most important class of drug targets for the pharmaceutical industry in the field of cancer. The development of novel specific kinase inhibitors may lead to the discovery of effective anti-cancer drugs.